00Author
Veron P. Browne, PhD
Co-Founder, Alenvo
Veron is a pharmacologist, toxicologist, and life-sciences executive with over 20 years of experience advancing drugs from discovery through clinical development. He specializes in translating complex scientific data into regulatory and commercial strategies that accelerate timelines and maximize portfolio value.
Articles
- Underwriting the Pathway
Due Diligence ·
- Reading the Record
NDA ·
- Operation TrialBlazer and the IND Readiness Premium
IND ·
- What the CRL Transparency Era Changes
NDA ·
More about the team on the About page. How articles are written and sourced is described in our editorial standards.